$MNKD
MANNKIND CORP

2013 Q4 Form 10-Q Financial Statement

#000119312513438214 Filed on November 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $0.00 $0.00 $35.00K
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $17.60M $17.50M $9.200M
YoY Change 69.23% 90.22% -4.17%
% of Gross Profit
Research & Development $29.00M $27.28M $25.45M
YoY Change 14.62% 7.18% 10.19%
% of Gross Profit
Depreciation & Amortization $3.950M $2.874M $3.237M
YoY Change 13.83% -11.21% -20.66%
% of Gross Profit
Operating Expenses $46.60M $44.76M $35.52M
YoY Change 30.9% 26.01% 8.3%
Operating Profit -$44.76M -$35.49M
YoY Change 26.14%
Interest Expense -$6.300M -$6.100M -$5.100M
YoY Change 26.0% 19.61% -10.53%
% of Operating Profit
Other Income/Expense, Net -$700.0K $10.00K -$2.651M
YoY Change -94.74% -100.38% -2751.0%
Pretax Income -$53.60M -$50.82M -$43.24M
YoY Change 3.47% 17.52% 12.61%
Income Tax $0.00 $0.00 -$408.0K
% Of Pretax Income
Net Earnings -$53.58M -$50.82M -$42.83M
YoY Change 3.48% 18.64% 11.54%
Net Earnings / Revenue -122382.86%
Basic Earnings Per Share
Diluted Earnings Per Share -$794.1K -$856.7K -$1.123M
COMMON SHARES
Basic Shares Outstanding 357.3M shares 301.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $70.80M $93.80M $2.100M
YoY Change 14.56% 4366.67% -90.99%
Cash & Equivalents $70.79M $93.80M $1.765M
Short-Term Investments $400.0K
Other Short-Term Assets $5.500M $5.200M $21.10M
YoY Change 22.22% -75.36% 603.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $76.28M $99.33M $23.20M
YoY Change 14.17% 328.14% -14.07%
LONG-TERM ASSETS
Property, Plant & Equipment $176.6M $177.8M $186.6M
YoY Change -4.02% -4.7% -4.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.516M $10.23M $500.0K
YoY Change 2298.26% 1945.4% -16.67%
Total Long-Term Assets $182.4M $188.3M $187.1M
YoY Change -1.16% 0.63% -5.03%
TOTAL ASSETS
Total Short-Term Assets $76.28M $99.33M $23.20M
Total Long-Term Assets $182.4M $188.3M $187.1M
Total Assets $258.6M $287.6M $210.3M
YoY Change 2.92% 36.76% -6.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.860M $7.786M $3.200M
YoY Change -15.26% 143.31% 100.0%
Accrued Expenses $21.63M $21.55M $47.10M
YoY Change -16.07% -54.24% 224.83%
Deferred Revenue
YoY Change
Short-Term Debt $102.3M $72.90M $0.00
YoY Change
Long-Term Debt Due $0.00 $114.9M
YoY Change -100.0%
Total Short-Term Liabilities $127.8M $217.2M $51.80M
YoY Change -11.73% 319.25% 199.42%
LONG-TERM LIABILITIES
Long-Term Debt $148.0M $217.9M $434.8M
YoY Change -31.86% -49.89% -10.81%
Other Long-Term Liabilities $13.61M $20.31M
YoY Change
Total Long-Term Liabilities $13.61M $20.31M $434.8M
YoY Change -93.74% -95.33% -10.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $127.8M $217.2M $51.80M
Total Long-Term Liabilities $13.61M $20.31M $434.8M
Total Liabilities $289.4M $455.3M $486.6M
YoY Change -20.07% -6.43% -3.61%
SHAREHOLDERS EQUITY
Retained Earnings -$2.296B
YoY Change
Common Stock $2.266B $2.075B
YoY Change 13.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$30.71M -$167.7M -$276.2M
YoY Change
Total Liabilities & Shareholders Equity $258.6M $287.6M $210.3M
YoY Change 2.92% 36.76% -6.12%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$53.58M -$50.82M -$42.83M
YoY Change 3.48% 18.64% 11.54%
Depreciation, Depletion And Amortization $3.950M $2.874M $3.237M
YoY Change 13.83% -11.21% -20.66%
Cash From Operating Activities -$34.05M -$32.91M -$34.26M
YoY Change 21.17% -3.94% -4.91%
INVESTING ACTIVITIES
Capital Expenditures -$6.170M -$230.0K -$120.0K
YoY Change 8714.29% 91.67% -79.66%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$6.170M -$230.0K -$120.0K
YoY Change 10183.33% 91.67% -79.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 17.20M 98.42M 4.510M
YoY Change -80.51% 2082.26% -86.98%
NET CHANGE
Cash From Operating Activities -34.05M -32.91M -34.26M
Cash From Investing Activities -6.170M -230.0K -120.0K
Cash From Financing Activities 17.20M 98.42M 4.510M
Net Change In Cash -23.02M 65.28M -29.87M
YoY Change -138.32% -318.55% 1416.24%
FREE CASH FLOW
Cash From Operating Activities -$34.05M -$32.91M -$34.26M
Capital Expenditures -$6.170M -$230.0K -$120.0K
Free Cash Flow -$27.88M -$32.68M -$34.14M
YoY Change -0.54% -4.28% -3.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
0.6 shares
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31250000 shares
CY2012Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
47300000
CY2012Q1 mnkd Issuance Of Common Stock And Warrants Gross Value
IssuanceOfCommonStockAndWarrantsGrossValue
86300000
CY2012Q1 mnkd Units Sold Under Public Offer Underwritten
UnitsSoldUnderPublicOfferUnderwritten
35937500 shares
CY2012Q1 mnkd Restricted Stock Agreed To Be Purchased By Lender
RestrictedStockAgreedToBePurchasedByLender
77200000
CY2012Q2 mnkd Fair Value Input Discount For Lack Of Marketability
FairValueInputDiscountForLackOfMarketability
0.0167 pure
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
2.60
CY2012Q4 mnkd Warrants Expiration Month And Year
WarrantsExpirationMonthAndYear
2013-10
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
357312740 shares
CY2012Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
0.6 shares
CY2012Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
2.40
CY2012Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
47300000
CY2012Q1 mnkd Increase Decrease In Fair Value Recognized In Other Income
IncreaseDecreaseInFairValueRecognizedInOtherIncome
-336000
CY2012Q1 mnkd Fair Value Input Discount For Lack Of Marketability
FairValueInputDiscountForLackOfMarketability
0.0164 pure
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31250000 shares
CY2012Q3 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1765000
CY2012Q3 mnkd Increase Decrease In Fair Value Recognized In Other Income
IncreaseDecreaseInFairValueRecognizedInOtherIncome
12000000
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
309993285 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q3 us-gaap Ownshare Lending Arrangement Shares Outstanding
OwnshareLendingArrangementSharesOutstanding
9000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
309993285 shares
CY2013Q3 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2013Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
213117000
CY2013Q3 us-gaap Interest Payable Current
InterestPayableCurrent
3265000
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
217169000
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9000
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9414000
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
109912000
CY2013Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5493000
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7786000
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20306000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
-167722000
CY2013Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
72933000
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2072006000
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21553000
CY2013Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
98220000
CY2013Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
119635000
CY2013Q3 us-gaap Liabilities
Liabilities
455330000
CY2013Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
114897000
CY2013Q3 us-gaap Construction Payable Current
ConstructionPayableCurrent
226000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
3100000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
287608000
CY2013Q3 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
119600000
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10227000
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
287741000
CY2013Q3 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
223000
CY2013Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
93800000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
177829000
CY2013Q3 us-gaap Assets
Assets
287608000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93803000
CY2013Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
298000
CY2013Q3 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
2242819000
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5228000
CY2013Q3 us-gaap Assets Current
AssetsCurrent
99329000
CY2013Q3 mnkd Total Accrued Expenses And Other Current Liabilities
TotalAccruedExpensesAndOtherCurrentLiabilities
21553000
CY2013Q3 mnkd Accrued Research And Clinical Trial Costs
AccruedResearchAndClinicalTrialCosts
3155000
CY2013Q3 mnkd Loan Commitment Asset
LoanCommitmentAsset
13393000
CY2013Q3 mnkd Preferred Stock Shares Undesignated
PreferredStockSharesUndesignated
10000000 shares
CY2013Q3 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
223000
CY2013Q3 mnkd Prepaid And Other Current Assets Under Credit Exchange Program
PrepaidAndOtherCurrentAssetsUnderCreditExchangeProgram
298000
CY2013Q3 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2013Q3 mnkd Loan Commitment Asset Noncurrent Portion
LoanCommitmentAssetNoncurrentPortion
9737000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2681000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
286035082 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
286035082 shares
CY2012Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
212026000
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
4533000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
144775000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10074000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
101249000
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1297000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4555000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-110679000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1991379000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
25777000
CY2012Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
97583000
CY2012Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
119635000
CY2012Q4 us-gaap Liabilities
Liabilities
361993000
CY2012Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
114443000
CY2012Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
3878000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2860000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
251314000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
285210000
CY2012Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
313000
CY2012Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
61800000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
183961000
CY2012Q4 us-gaap Assets
Assets
251314000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61840000
CY2012Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
450000
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
2104912000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4520000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
66810000
CY2012Q4 mnkd Total Accrued Expenses And Other Current Liabilities
TotalAccruedExpensesAndOtherCurrentLiabilities
25777000
CY2012Q4 mnkd Accrued Research And Clinical Trial Costs
AccruedResearchAndClinicalTrialCosts
5995000
CY2012Q4 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
313000
CY2012Q1 us-gaap Partners Capital Account Public Sale Of Units
PartnersCapitalAccountPublicSaleOfUnits
86300000
CY2012Q4 mnkd Prepaid And Other Current Assets Under Credit Exchange Program
PrepaidAndOtherCurrentAssetsUnderCreditExchangeProgram
450000
CY2012Q4 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2012Q1 us-gaap Partners Capital Account Units Sold In Public Offering
PartnersCapitalAccountUnitsSoldInPublicOffering
35937500 shares
CY2012Q1 mnkd Net Proceeds From Public Offering
NetProceedsFromPublicOffering
80600000
CY2012Q1 mnkd Proceeds From Exercise Of Warrants
ProceedsFromExerciseOfWarrants
4500000
CY2012Q1 mnkd Warrant Expiry Period
WarrantExpiryPeriod
2016-02
dei Trading Symbol
TradingSymbol
MNKD
dei Entity Registrant Name
EntityRegistrantName
MANNKIND CORP
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000899460
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-94681000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
133944425 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-137910000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1821000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
598000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-137907000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
5523000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48000
us-gaap Interest Paid
InterestPaid
7862000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-137907000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
708000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3000
us-gaap Operating Income Loss
OperatingIncomeLoss
-122784000
us-gaap Net Income Loss
NetIncomeLoss
-137907000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42053000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1091000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
128465000
us-gaap Share Based Compensation
ShareBasedCompensation
31304000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10109000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
31963000
us-gaap Proceeds From Issuance Of Financial Services Obligations
ProceedsFromIssuanceOfFinancialServicesObligations
79500000
us-gaap Interest Expense Debt
InterestExpenseDebt
10052000
us-gaap Operating Expenses
OperatingExpenses
122784000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
49170000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1929000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
80731000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8820000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31304000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1821000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
5123000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3525000
mnkd Nominal Lending Fee
NominalLendingFee
0.01
mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
286889000 shares
mnkd Amortization Period Of Lease Hold Improvements
AmortizationPeriodOfLeaseHoldImprovements
P4Y
mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-686000
mnkd Payment Of Employment Taxes Related To Vested Restricted Stock Units
PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits
2095000
mnkd Percentage Of Credit Exchange Receivable
PercentageOfCreditExchangeReceivable
0.65 pure
mnkd Related Party Transaction Prepayment Period
RelatedPartyTransactionPrepaymentPeriod
P90D
mnkd Maturity Period Of Cash Equivalents
MaturityPeriodOfCashEquivalents
90 days or less at the time of purchase
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
242000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
2488000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-91762000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
63833521 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
us-gaap Sales Revenue Net
SalesRevenueNet
35000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
572000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
12011000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-117585000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
2907000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12078000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
48000
us-gaap Interest Paid
InterestPaid
7626000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-117993000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18007000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-117533000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
4000
us-gaap Operating Income Loss
OperatingIncomeLoss
-113474000
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-117000
us-gaap Net Income Loss
NetIncomeLoss
-117585000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
4000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
52000
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-270000
mnkd Reclassification Of Forward Purchase Contract To Additional Paid In Capital
ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital
13091000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
11876000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37262000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1031000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
91345000
us-gaap Share Based Compensation
ShareBasedCompensation
9770000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10929000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-916000
us-gaap Interest Expense Debt
InterestExpenseDebt
8278000
us-gaap Operating Expenses
OperatingExpenses
113509000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-408000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1526000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
73000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
76247000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9898000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
11250000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9770000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-499000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-48000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
8321000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
36898000
mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
164611000 shares
mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
73000
mnkd Payment Of Employment Taxes Related To Vested Restricted Stock Units
PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits
887000
mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
77187000
mnkd Forward Purchase Contract Contribution To Additional Paid In Capital
ForwardPurchaseContractContributionToAdditionalPaidInCapital
1080000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
80982000
CY2012Q1 mnkd Warrant Expiration Month Year
WarrantExpirationMonthYear
2016-02
CY2012Q1 mnkd Proceeds From Exercise Of Warrants
ProceedsFromExerciseOfWarrants
4500000
CY2012Q1 mnkd Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
80600000
CY2012Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
46000000 shares
CY2012Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
92000000
CY2012Q4 mnkd Net Proceeds From Public Offering
NetProceedsFromPublicOffering
86300000
CY2012Q4 mnkd Number Of Shares Of Common Stock In Each Unit
NumberOfSharesOfCommonStockInEachUnit
1 shares
CY2012Q4 mnkd Common Stock Issuable Upon Exercise Of Warrants Conversion Ratio
CommonStockIssuableUponExerciseOfWarrantsConversionRatio
0.75 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1690942000
us-gaap Sales Revenue Net
SalesRevenueNet
3166000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
329567000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1237000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
48000
us-gaap Income Taxes Paid
IncomeTaxesPaid
26000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
598000
us-gaap Investment Income Interest
InvestmentIncomeInterest
37000000
us-gaap Stock Issued1
StockIssued1
2758000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
230000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
796779000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2266031000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1667000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
5523000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2219000
us-gaap Interest Paid
InterestPaid
67014000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2243201000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3278000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2242828000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1096000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2184049000
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-990000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
70000000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-6494000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1028000
us-gaap Net Income Loss
NetIncomeLoss
-2242819000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-9000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3331000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
14219000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
5248000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3460000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
467757000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2114244000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
952000
us-gaap Share Based Compensation
ShareBasedCompensation
169222000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
136886000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
93803000
us-gaap Proceeds From Issuance Of Financial Services Obligations
ProceedsFromIssuanceOfFinancialServicesObligations
79500000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
15000000
us-gaap Interest Expense Debt
InterestExpenseDebt
49985000
us-gaap Operating Expenses
OperatingExpenses
2187215000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
207050000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-382000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1742000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
49170000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2489000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3900000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
454000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1548304000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
4220000
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
22260000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
387750000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
151428000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
19726000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
796393000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-329499000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
48000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
43948000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
38574000
mnkd Collection Of Convertible Preferred Stock Subscriptions Receivable
CollectionOfConvertiblePreferredStockSubscriptionsReceivable
50000000
mnkd Accrued Interest On Investments Net Of Amortization Of Discounts
AccruedInterestOnInvestmentsNetOfAmortizationOfDiscounts
191000
mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-24939000
mnkd Payment Of Employment Taxes Related To Vested Restricted Stock Units
PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits
15122000
mnkd Issuance Of Put Option By Stockholder
IssuanceOfPutOptionByStockholder
2949000
mnkd Put Option Redemption By Stockholder
PutOptionRedemptionByStockholder
1921000
mnkd Stock Expense For Shares Issued Pursuant To Research Agreement
StockExpenseForSharesIssuedPursuantToResearchAgreement
3018000
mnkd Put Shares Sold To Majority Stockholder
PutSharesSoldToMajorityStockholder
623000
mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
212334000
mnkd Issuance Of Redeemable Convertible Preferred Stock
IssuanceOfRedeemableConvertiblePreferredStock
4296000
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-521000
mnkd Reclassification Of Forward Purchase Contract To Additional Paid In Capital
ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital
28080000
mnkd Forward Purchase Contract Contribution To Additional Paid In Capital
ForwardPurchaseContractContributionToAdditionalPaidInCapital
29317000
mnkd Increase In Additional Paid In Capital Resulting From Merger
IncreaseInAdditionalPaidInCapitalResultingFromMerger
171154000
mnkd Issuance Of Convertible Preferred Stock Subscriptions
IssuanceOfConvertiblePreferredStockSubscriptions
50000000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
1400244000
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2013Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
732350 shares
CY2013Q3 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
1106000 shares
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50818000
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-50818000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50819000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-44762000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-50818000
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1000
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17481000
CY2013Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
369000
CY2013Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
4323000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
44762000
CY2013Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
27281000
CY2013Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2874000
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15943000
CY2013Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
1745000
CY2013Q3 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
296386000 shares
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
35000
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-42834000
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2651000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-43242000
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42835000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-35487000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-42834000
CY2012Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1000
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10069000
CY2012Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
348000
CY2012Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2859000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
35522000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-408000
CY2012Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
25453000
CY2012Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3237000
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3820000
CY2012Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
2245000
CY2012Q3 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
190534000 shares

Files In Submission

Name View Source Status
0001193125-13-438214-index-headers.html Edgar Link pending
0001193125-13-438214-index.html Edgar Link pending
0001193125-13-438214.txt Edgar Link pending
0001193125-13-438214-xbrl.zip Edgar Link pending
d598219d10q.htm Edgar Link pending
d598219dex311.htm Edgar Link pending
d598219dex312.htm Edgar Link pending
d598219dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mnkd-20130930.xml Edgar Link completed
mnkd-20130930.xsd Edgar Link pending
mnkd-20130930_cal.xml Edgar Link unprocessable
mnkd-20130930_def.xml Edgar Link unprocessable
mnkd-20130930_lab.xml Edgar Link unprocessable
mnkd-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending